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Peptidyl-prolyl cis-trans isomerase C (Ppic) is expressed in several bone marrow (BM)
hematopoietic progenitors and in T-cell precursors. Since the expression profile of Ppic
in the hematoimmune system was suggestive that it could play a role in hematopoiesis
and/or T lymphocyte differentiation, we sought to test that hypothesis in vivo. Specifi-
cally, we generated a Ppic-deficient mouse model by targeting the endogenous locus by
CRISPR/Cas9 and tested the requirement of Ppic in hematopoiesis. Several immune cell
lineages covering BM progenitors, lymphocyte precursors, as well as mature cells at the
periphery were analyzed.While most lineages were unaffected, invariant NKT (iNKT) cells
were reduced in percentage and absolute cell numbers in the Ppic-deficient thymus. This
affected the most mature stages in the thymus, S2 and S3, and the phenotype was main-
tained at the periphery.Additionally, immature transitional T1 and T2 B lymphocyteswere
increased in the Ppic-deficient spleen, but the phenotype was lost in mature B lympho-
cytes. In sum, our data show that Ppic is dispensable for myeloid cells, platelets, erythro-
cytes, αβ, and γδ T lymphocytes in vivo in the steady state, while being involved in B- and
iNKT cell differentiation.
Keywords: Peptidylprolyl isomerase C  Cyclophilin C  Hematopoiesis  Ppic  T-cell develop-
ment  Thymopoiesis
 Additional supporting information may be found online in the Supporting Information sectionat the end of the article.
Introduction
The gene Peptidyl-prolyl cis-trans isomerase C (Ppic, Cypc;
EC:5.2.1.8) is expressed in hematopoietic progenitors in the
bone marrow, and in T-cell precursors, or thymocytes, in the
thymus. PPIC function has been mostly studied in vitro or in
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association studies in human and rat. PPIC is a Peptidyl-prolyl
isomerase (or PPIase) that interconverts cis and trans isomers
of peptide bonds with proline, and binds to different protein
partners dependent on the presence of cyclosporine A (CsA)
[1]. While it belongs to a gene family containing eight members
(Ppia, Ppib, Ppic, Ppid, Ppie, Ppif, Ppig, Ppih), Ppic is the family
member with the most restricted pattern of tissue expression
[1]. PPIC expression was detected in specific kidney structures
that are sensitive to CsA-mediated nephrotoxicity, suggestive of
© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH www.eji-journal.eu
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and
distribution in anymedium, provided the original work is properly cited, the use is non-commercial and nomodifications or adaptations are made.
2 Ricardo S. Paiva et al. Eur. J. Immunol. 2021. 00: 1–12
a role in CsA-induced kidney damage [2, 3]. Nevertheless, PPIC
overexpression in Jurkat T lymphocytes did not alter their sensi-
tivity to CsA dependent changes in calcium signaling, challenging
the former hypothesis [4]. PPIC has also been reported to be
an ER cyclophilin participating in the regulation of ER redox
state together with cyclophilin B [5]. Additionally, PPIC, as well
as cyclophilin A and B, has DNA cleaving activity suggestive
that it might play a role during apoptosis [6]. Further studies
linking PPIC expression to disease included human glioma, for
which increased expression levels correlated with worse survival
prognosis [7]. In coronary heart disease, PPIC serum levels can be
used as a diagnostic marker [8]. Further, PPIC was upregulated
following brain ischemia in a rat model [9]. Finally, PPIC binding
to CD147 and osteopontin led to increased metastatic activity in
a mouse model of breast cancer in vitro [10].
While few studies addressed Ppic function in vivo, we detected
that the gene was differentially expressed in thymocytes under-
going cell competition [11], a process whereby thymocytes at the
same differentiation stage, but short time of thymus residency,
outcompete others with longer dwell time in the thymus [12].
The regulated expression profile of Ppic was, therefore, sugges-
tive that Ppic could be involved in the differentiation of T lym-
phocytes and/or of other hematopoietic cell lineages. With the
purpose of addressing the function of Ppic in vivo, and testing its
involvement in the hematoimmune system, we generated a Ppic-
deficient mouse model. We assessed different progenitors and
cell lineages of the hematoimmune system and show that Ppic-
deficient mice have a defect in iNKT cell differentiation in the
thymus, and reduced cell numbers of iNKT in the spleen. We also
found that immature transitional T1 and T2 B cells are increased
in the spleen, but B lymphocyte precursors in the bone marrow
(BM), as well as the mature B cell populations, are unaffected.
These data suggest that Ppic is dispensable for early hematopoiesis
and the differentiation and homeostasis of myeloid cells, erythro-
cytes, platelets, αβ, and γδ T cells. Nevertheless, it is involved in
a short window of late B cell development in the spleen, and in
iNKT cell differentiation in the thymus, which determines iNKT
cell numbers at the periphery.
Results
Targeting of the Ppic endogenous locus by
CRISPR/Cas9
We sought to test whether Ppic was involved in the differen-
tiation and homeostasis of the hematoimmune system. Using
gene expression data from the database ImmGen [13], we
confirmed that Ppic was expressed in hematopoietic stem and
progenitor cells in the BM, as well as B- and T- lymphocyte
precursors, and their mature counterparts (Fig. 1A). In the
thymus, Ppic expression seemed to be regulated and highest
at the differentiation stages undergoing cell competition, the
DN2 to DN3 (Fig. 1A). Ppic expression was indeed consistent
with a potential role in early hematopoiesis and T lymphocyte
Figure 1. Generation of Ppic-deficient mice. (A) Ppic expression levels
as measured by RNA seq were retrieved from the ImmGen Database
[13] for the indicated cell populations in the BM (top), thymus (middle),
and spleen (bottom). (B) Schematic representation of the Ppic endoge-
nous locus (not to scale) showing the sequence targeted by the gRNA
(magenta, in capitals), with the ATG (bold) and protospacer-adjacent
motif (underline) highlighted, and the primers used to genotype the
progeny (arrows flanking exon 1). (C) Schematic representation of the
wild type (Ppic WT, top) and mutant (Ppic Mut, bottom) predicted cDNA.
Below is the alignment of the WT and mutant sequences of Ppic, high-
lighting the 4-nucleotide insertion in the latter that causes a frameshift
followed by early STOP codons, which are marked in the schematics by
red triangles.
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differentiation, validating it as an interesting candidate gene with
a potential role in hematopoiesis. To test Ppic function in vivo,
we engineered Ppic-deficient mice. The endogenous locus was
targeted by CRISPR/Cas9 in the B6 background, using a guide
RNA (gRNA) specific to the region immediately downstream of
the ATG (Fig. 1B). Two founders were generated, each bearing
specific mutations that disrupted the gene and were therefore
functionally identical. Though both founders were used to start
two independent lines, most experiments used only the line with
a 4-nucleotide insertion downstream of the ATG, which caused
a +1 frameshift in the reading frame and several early STOP
codons (Fig. 1C). The founder was crossed with a WT B6 and
their progeny intercrossed to establish the Ppic-deficient mouse
line, thereby setting the conditions to examine the role of Ppic in
the immune system in vivo.
Ppic deficiency does not affect hematopoietic
progenitors in the bone marrow
To test if Ppic plays a role in the maintenance of the most imma-
ture hematopoietic progenitors, we analyzed the BM of Ppic−/−
mice by flow cytometry and compared it to gender and age-
matched Ppic+/+ controls. We assessed the population defined as
Lineage-negative, Sca-1-positive, Kit-positive (LSK), that contains
the hematopoietic stem and progenitor cells, and found no differ-
ences in relative and in absolute cell numbers between Ppic−/−
and Ppic+/+ (Fig. 2A and B). Detailing the HSC compartment fur-
ther for long-term HSC (LT-HSC), short-term HSC (ST-HSC), as
well as multipotent progenitors 2 to 4 (MPP2-MPP4), showed
no differences in relative (Fig. 2C-E) and absolute cell numbers
(Fig. 2F) between Ppic−/− and Ppic+/+. Next, we assessed com-
mon myeloid progenitors (CMP), granulocyte-monocyte progen-
itors (GMP) and megakaryocyte-erythrocyte progenitors (MEP),
and found that none differed between Ppic−/− and Ppic+/+ mice
in relative or absolute cell numbers (Fig. 2G and H). This was
in line with no detectable differences in erythrocytes (Supporting
information Fig. S1A) or platelets (Supporting information Fig.
1B) in the blood of adult mice. In addition, no differences were
found between Ppic−/− and Ppic+/+ in several myeloid lineages
in the spleen, namely macrophages (Supporting information Fig.
S2A and B), neutrophils (Supporting information Fig. S2C and D),
conventional Dendritic Cells (DCs ) (Supporting information Fig.
S2E and F), and plasmacytoid DCs (Supporting information Fig.
S2G and H). Finally, we assessed and quantified common lym-
phoid progenitors (CLP) and also detected no differences in the
Ppic−/− BM (Fig. 2I and J). Altogether, these data indicate that
Ppic deficiency does not impact on the numbers of the BM pro-
genitors tested, and is dispensable for circulating erythrocytes and
platelets, as well as myeloid lineages in the spleen at steady state.
Ppic-deficient mice have an increase in transitional T1
and T2 B cells in the spleen
To address B lymphocytes, we analyzed the early stages of differ-
entiation and found no differences between Ppic−/− and Ppic+/+
mice from the pre-proB through the immature B lymphocytes in
the BM (Fig. 3A). In the spleen, an increase in the number of
immature transitional T1 and T2 was detected (Fig. 3B). Never-
theless, no phenotype was found in other B cell subsets, including
T3 (Fig. 3B), follicular, marginal zone, and B1-mature B lympho-
cytes (Fig. 3C), or circulating mature B lymphocytes in the BM
(Fig. 3A). Taken together, the data suggest that Ppic might play a
role in the migration of the immature B cells from the BM to the
spleen, or in the generation of T1 transitional B cells, but this phe-
notype is compensated during differentiation in the spleen and
mature B cells were not affected in numbers in the Ppic-deficient
mice.
Ppic deficiency has no influence on αβ T lymphocyte
differentiation
To test whether Ppic is involved in αβ T lymphocyte differentia-
tion in the thymus, we analyzed Ppic-deficient thymocytes. The
main thymocyte populations can be defined based on the expres-
sion of CD4 and CD8. The most immature thymocytes lack the
expression of both CD4 and CD8, and hence, are termed double
negative (DN). DN differentiate into CD4+CD8+ double-positive
(DP) thymocytes, which finally downregulate either CD4 or CD8
to commit to the CD8 or CD4 T cell lineages, respectively. Ppic-
deficient thymocytes did not differ from the controls in percent-
age (Fig. 4A) or absolute cell numbers at the DP and single-
positive stages of differentiation (Fig. 4B). Double-negative thy-
mocytes can be further detailed by gating on CD3-negative precur-
sors and discriminated with basis on the differential expression of
CD25, CD44, and Kit. No difference was detected in the immature
subsets of differentiating T cell precursors, from the most imma-
ture early T-lineage progenitor (ETP, Kit+CD44+CD25−), through
DN2 (Kit+/loCD44+CD25+), DN3 (Kit−CD44−CD25+), and DN4
(Kit−CD44−CD25−) in relative and absolute cell numbers (Fig. 4C
and D). These results were consistent with the absence of pheno-
type in Ppic-deficient embryos (E17.5) and newborn mice (Sup-
porting information Fig. S3A-D). Next, we tested whether Ppic
deficiency could impact cell competition in the thymus. Cell com-
petition occurs between thymocytes included in the DN2 and DN3
stages that differ in time of thymus residency [14]. For that pur-
pose, we transplanted WT newborn thymi into Ppic−/− or Ppic+/+
recipients and compared the kinetic of thymus turnover in the
two types of thymus grafts (Supporting information Fig. S4A).
No difference was detected between Ppic−/− or Ppic+/+ thymo-
cytes of host origin, excluding Ppic from a functional role in cell
competition (Supporting information Fig. S4B and C). Consistent
with the absence of phenotype in the thymus, αβ T lymphocytes
were also similar between the spleen of Ppic−/− and Ppic+/+ mice,
with CD4 and CD8 T lymphocytes virtually identical for relative
and absolute cell numbers (Fig. 4E and F), and a normal CD4 to
CD8 ratio (Fig. 4G). Similarly, Foxp3-expressing regulatory T cells
were not affected in relative or absolute cell number in the thy-
mus (Supporting information Fig. S5A and B), or the spleen (Sup-
porting information Fig. S5C and D). Finally, we performed com-
petitive BM chimeras in which either Ppic−/− or Ppic+/+BM was
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Figure 2. Ppic deficiency does not affect the hematopoietic progenitors in the BM.The BM of age- and gender-matched Ppic+/+ and Ppic−/− micewere
analyzed by flow cytometry. (A) Shown are FACS plots of the gate used for LSK in live lineage-negative cells. (B) Quantification of the absolute cell
numbers in (A). (C) FACS plots of LSK-gated cells, as in (A), defining: hematopoietic stem cells (HSC), further analyzed in (D),multipotent progenitors
(MPP) 2, and MPP3-4, further detailed in (E) (from left to right and top to bottom). (D) HSC were further gated to distinguish long-term HSC (LT-HSC,
left gate) and short-term HSC (ST-HSC, right gate). (E) MPP3-4 in (C) were further gated to distinguish MPP3 (top gate) and MPP4 (bottom gate).
(F) Quantification of the absolute number of cells in (C), (D), and (E). (G) Cells shown were gated on Lineage-negative, Kit-positive, Sca1-negative,
CD127-negative, and gates correspond to MEP, GMP, and CMP (left to right and top to bottom). (H) Quantification of the absolute cell numbers in (G).
(I) FACS plots of the gate used for CLP, showing cells gated on lineage-negative cells. (J) Quantification of the absolute cell numbers in (H). Numbers
above the gates represent mean ± SD of the percentages of the corresponding gate in one representative experiment (A, C, D, E, G, I). In the graphs
depicting the quantification of absolute numbers, cells were normalized to 105 live BM cells. Each symbol represents one mouse and the horizontal
line is the mean (B, F, H, J). Data shown are from one representative experiment of a total of three independent experiments, each with a minimum
n = 3 mice per group. Mann–Whitney U test revealed no statistical difference.
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Figure 3. Ppic−/− mice have an increase in immature transitional T1 and T2 B cells in the spleen. (A) The BM of Ppic+/+ and Ppic−/− mice were
analyzed for the indicated cell populations, and cell numbers were normalized for 105 total live BM cells. (B) Shown is the cell number of the
indicated subpopulations in the spleen. (C) Cell number of the indicated mature B-cell subsets in the spleen. Each symbol represents one mouse
and the horizontal line is the mean. Data are from one representative of a total of three independent experiments, each with a minimum n = 3
mice per group. *p < 0.05 Mann–Whitney U test.
mixed at 1:1 proportions with WT congenic BM and transferred
into irradiated F1(B6xB6.SJL) recipients. In agreement with the
data from the steady-state analyses, no differences were found
in the engraftment capacity of Ppic−/− or Ppic+/+ cells, or in the
hematopoietic capacity for generating all cell lineages assessed,
as measured by the normalized ratio of Ppic−/− or Ppic+/+ to the
competitor BM (Supporting information Fig. S6A) or in absolute
cell numbers (Supporting information Fig. S6B). These analyses
show that Ppic deficiency does not affect αβT cell development or
homeostasis in the steady state.
Ppic deficiency has no influence on γδ T lymphocyte
differentiation
γδT lymphocytes also differentiate in the thymus and diverge from
the αβ T cell lineage at an early stage of differentiation. We found
that γδ T lymphocytes were present in the Ppic−/− and Ppic+/+
thymi in identical percentages (Fig. 5A) and absolute numbers
(Fig. 5B). γδ T lymphocyte differentiation can be detailed with
basis on the expression of CD25 and CD27 [15] (Fig. 5C). No dif-
ferences were found in the most immature CD25+CD27+ precur-
sors, the IFN-γ producing CD27+, or the IL 17 producing CD27−
subsets (Fig. 5C and D). Similar results were observed in the
embryo at E17.5 and in newborn thymi (Supporting information
Fig. S7A-D). Further, the T cell receptor repertoire was not obvi-
ously altered, as assessed with basis on the expression of the most
prevalent Vγ chains in the embryo, in the newborn (Supporting
information Fig. S7E and F), or the adult thymus (Fig. 5E and F).
Likewise, no differences were found in the spleen of adult mice
in percentage or absolute number (Fig. 5G and H) of γδ T lym-
phocytes, or differential usage of Vγ chains (Fig. 5I and J). Taken
together, Ppic deficiency did not affect γδ T lymphocyte differen-
tiation or homeostasis in the steady state.
Ppic deficiency leads to a reduction in iNKT cells
Last, we assessed if Ppic could be involved in iNKT cell differentia-
tion and/or maintenance at the periphery. iNKT cells are a particu-
lar subset of αβ T lymphocytes that display properties of classical
CD4 and CD8 αβ T lymphocytes and NK cells. They are termed
invariant due to a reduced Vα and Vβ TCR chain segment utiliza-
tion and they divert from the classical αβ T cell lineage when the
αβ TCR from thymocytes at the DP stage interact with glycolipid
loaded nonclassical MHC molecule CD1d presented by other DP
cells. These thymocytes then downregulate CD8 and present high
expression of CD24 and CD69, with low levels of CD44 (Stage 0),
and will then be on the iNKT developmental pathway. At this early
stage, iNKT cell precursors will undergo further TCR stimulation
and differentiate into iNKT cells that are exported to the periph-
ery [16]. Focusing first on the thymus, we found that iNKT cells
were reduced among thymocytes of Ppic−/− mice (Fig. 6A and B).
This reduction was due to a decrease in the later stages of differ-
entiation, S2 (CD44hiNK1.1−) and S3 (CD44+NK1.1+), while the
earlier stages S0/S1 (CD44−/loNK1.1-) were comparable to those
of WT control mice (Fig. 6C and D). A similar decrease of iNKT
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Figure 4. αβ Tcell development is unaffected in Ppic−/− mice. (A) Thymοcytes of age- and gender-matched Ppic+/+ and Ppic−/− mice were analyzed
by flow cytometry for the indicated markers. (B) Absolute cell numbers were quantified for CD4+CD8+ double positive (DP), CD8 single positive
(CD8SP), and CD4 single positive (CD4SP) gated as in (A). (C) CD4−CD8− double-negative thymocytes in (A) were further gated as CD3-negative and
analyzed for the indicatedmarkers. Gates from top left to bottom right identify early thymus progenitors (ETP), the double-negative 2 (DN2), and the
double-negative 3 (DN3) thymocytes. (D) Quantification of the absolute number of cells in (C), as well as DN4 (CD117−CD25−CD44−). (E) The spleen
of the same animals was analyzed and shown are representative histograms of live cells, showing the identification of αβ T lymphocytes (top),
further gated (below) as CD4 and CD8 T lymphocytes. (F) Quantification of the absolute cell numbers in (E). (G) Ratio of CD4 to CD8 T lymphocytes
in the spleen. Numbers in the FACS plots are the mean ± SD of the percentage of the populations gated in one representative experiment (A, C, E).
Each symbol represents one mouse and the horizontal line is the mean (B, D, F, G). Data are from one representative of a total of six independent
experiments each with a minimum n = 3 mice per group. Mann–Whitney U test revealed no statistical differences.
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Figure 5. γδ Tcell development is
unaffected in Ppic−/− mice. Thymo-
cytes of age- and gender-matched
Ppic+/+ and Ppic−/− mice were ana-
lyzed by flow cytometry (A-F). (A)
Representative FACS plots of the gate
used for defining γδ T lymphocytes,
depicting cells gated on CD4-CD8-
double negative. (B) Quantification of
the absolute cell numbers in (A). (C)
γδ T lymphocytes gated in (A) were
further gated as shown for the dis-
tinction of differentiation stages. (D)
Quantification of the absolute num-
ber of cells gated in (C). (E) γδ T lym-
phocytes gated in (A) were further
gated as shown for the expression
of the Vγ distribution. (F) Quantifi-
cation of the absolute cell numbers
in (E). Splenocytes of the same mice
were analyzed (G-J). (G) Representa-
tive FACS plots of the gate used for
defining γδ T lymphocytes, depicting
cells gated on live cells. (H) Quan-
tification of the absolute number of
cells gated in (G). (I) γδ T lympho-
cytes gated in (G) were further gated
as shown for the expression of the
Vγ distribution. (J) Quantification of
the absolute cell numbers as gated
in (I). Values in the FACS plots are
the mean ± SD of the percentages of
the populations gated in one repre-
sentative experiment (A, C, E, G, I).
Each symbol represents one mouse
and the horizontal line is the mean
(B, D, F, H, J). Data are from one repre-
sentative of a total of three indepen-
dent experiments each with a min-
imum n = 3 mice per group. Mann–
Whitney U test revealed no statisti-
cal differences.
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Figure 6. iNKT cell differentiation is impaired in Ppic-deficient mice, and the phenotype persists in the spleen. Thymocytes of age- and gender-
matched Ppic+/+ and Ppic−/− mice were analyzed by flow cytometry to assess iNKT cell development (A-D). (A) Representative FACS plots of the
gate used for defining iNKT cells, depicting live thymocytes and identifying PBS57-loaded CD1d tetramers versus TCR-β. (B) Quantification of the
absolute number of cells in (A). (C) iNKT cells in (A) were further analyzed as shown for the distinction of differentiation stages. (D) Quantification
of the absolute number of cells gated in (C). Splenocytes of the same mice were analyzed (E-H). (E) Representative FACS plots of the gate used for
defining iNKT cells, depicting live cells. (F) Quantification of the absolute number of cells in (E). (G) iNKT cells gated in (E) were further gated as
shown to define functional subsets. (H) Quantification of the absolute number of cells in (G). Values in the FACS plots are the mean ± SD of the
gated populations in one representative experiment (A, C, E, G). Each symbol represents one mouse and the horizontal line is the mean (B, D, F, H).
Data are from one representative of a total of two independent experiments each with a minimum n = 3 mice per group. *p < 0.05 Mann–Whitney
U test.
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cells was observed at the periphery (Fig. 6E and F), consequence
of a reduction in total numbers of NK1.1+ subpopulations (Fig. 6G
and H). These data show that Ppic has a role in the differentiation
of iNKT, which is maintained at the periphery in the steady state.
Discussion
Ppic is expressed by several cell lineages of the hematopoietic
system and was previously identified as differentially expressed
in thymocytes undergoing cell competition [11]. To functionally
address the involvement of Ppic in the immune system, we have
generated a Ppic-deficient mouse line and thoroughly assessed
hematopoietic progenitors, as well as several immune cell lin-
eages. Our data show that Ppic is dispensable for the develop-
ment and homeostasis of most hematoimmune cells. However, in
B lymphocyte differentiation, Ppic deficiency caused an increase
in immature transitional T1 and T2 that might be explained by a
more efficient homing to the spleen or an increased efficiency in
generating these stages. While the causes remain to be tested, the
phenotype was corrected in mature B lymphocyte subpopulations.
Interestingly, we found one lineage of nonconventional T lym-
phocytes, the iNKT cells, which were reduced in Ppic-deficient
mice. In the thymus, iNKT cells were reduced from the stages S2
and S3. It will be interesting to test whether these differences are
due to an effect of Ppic in proliferation, cell death, or differentia-
tion of iNKT in the thymus. Alternatively, there may be an impact
after CD4+CD8+ DP thymocytes are diverted to the iNKT cell lin-
eage that affects the progression of the cells to the S2 and S3
stages.
The reduced numbers of iNKT were maintained in the Ppic-
deficient spleen, suggestive that the cells cannot compensate the
differentiation deficiency at the periphery, or that Ppic is also
important for the homeostasis of mature iNKT. The reduction of
iNKT was most relevant for the subsets expressing NK1.1, and
while some degree of plasticity has been observed in iNKT cell
subsets [16], previous reports have shown that iNKT classification
with respect to CD4 and NK1.1 expression identifies subsets of
functionally distinct iNKT subsets (such as iNKT1, iNKT2, iNKT17,
and iNKT9 cells [17–19]). The skewing toward NK1.1− subsets in
Ppic−/− mice may, thus, imply an alteration in the functional pro-
file of iNKT cells [16–19]. It will be interesting to determine if the
impact of Ppic deficiency rests mainly in the thymus differentia-
tion process, and the export of an altered subset composition is
sufficient to establish an altered peripheral iNKT cell pool, or if it
also affects the homeostasis and polarization of iNKT cells at the
periphery. Future work will focus on evaluating these potential
mechanisms and their molecular basis for the impact of Ppic defi-
ciency in the development and homeostasis of iNK T cells reported
in this study as well as its role upon challenges such as infections.
The lack of additional phenotypes in Ppic−/− mice, particu-
larly in the populations with highest Ppic expression might be
explained by some redundancy with other Ppic family members.
Indeed, the Ppiase family is comprised of eight Ppiase and seven
Ppiase-like proteins in mice, several of which are expressed in the
same cell populations expressing Ppic. While the degree of homol-
ogy at DNA level reaches at best only 50-65% with other two fam-
ily members, it will remain to be tested whether there is some
degree of functional overlap between proteins of the same family.
Materials and methods
Mice
C57BL/6J (B6, CD45.2, designated here Ppic+/+) were bred and
kept at the Instituto Gulbenkian de Ciência (IGC) in a colony that
is refreshed frequently with mice purchased from Charles River.
B6.SJL-Ptprca Pep3b/BoyJ (CD45.1+, here termed B6.SJL) mice,
stock #002014, were purchased from The Jackson Laboratory
and kept in a colony at IGC. F1(B6xB6.SJL) (CD45.1+CD45.2+)
resulted from the intercross between B6 and B6.SJL parents, and
were used at 8-12 weeks of age. For embryonic stage E17.5 anal-
yses, females and males were joined overnight and checked the
next morning. Females that presented vaginal plugs (considered
gestation day E0.5) were monitored and embryos collected at
E17.5. Newborn thymi were analyzed at the day of birth. All
mouse lines were maintained in individually ventilated cages in
specific pathogen-free conditions, and all experiments were con-
ducted in compliance with Portuguese and European laws and
approved by the Ethics Committee of the IGC–Fundação Calouste
Gulbenkian and the Direção Geral de Alimentação e Veterinária
(DGAV).
Generation of Ppic−/− mouse line
The Ppic mutant allele was generated through a CRISPR/Cas9-
mediated disruption of the gene. One gRNA was used to
target exon 1 of Ppic immediately downstream of the ATG,
corresponding to the sequence 5′-CCACCGCGCACCATGAGCCC-
3′ in exon 1, which is followed by a protospacer-adjacent
motif sequence. The gRNA sequence was verified and gives
no predicted off targets, even if considering 1 or 2 mis-
matches. The gRNA was generated by transcription from the
gRNA-pUTB7 plasmid. This plasmid was built by hybridizing
oligonucleotides F:5′-AGGGCCACCGCGCACCATGAGCCC-3′ and
R:5′-AAACGGGCTCATGGTGCGCGGTGG-3′ to generate a ds DNA
fragment that leaves AGGG and TTTG overhangs to allow direc-
tional cloning into the BbsI sites of the gRNA basic plasmid [20].
After sequence confirmation, the gRNA was linearized with FspI
and transcribed with T7 RNA polymerase using the MEGAshort-
scriptTM kit (Ambion) according to the manufacturer’s protocol.
The DNA template was then digested with DNaseI and the gRNA
purified with the MEGAclearTM RNA purification kit (Ambion).
The Cas9 protein was a gift from Juan Galcerán (Instituto de Neu-
rociencias CSIC-UMH, Alicante, Spain) to M Mallo at the Trans-
genics Unit of the IGC. To generate the Ppic mutant mice, a mix
containing the gRNA (10 ng/μL), Cas9 protein (100 ng/μL), and
the replacement oligo (10 ng/μL) in 10 mM Tris-HCl pH7.5;
© 2021 The Authors. European Journal of Immunology published by
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0.1 mM EDTA, was introduced into fertilized B6 mouse oocytes,
at single-cell stage, by pronuclear microinjection at the Trans-
genics Unit of the IGC. Although a homologous recombination
approach had been chosen, in which a donor sequence was coin-
jected with the objective of inserting three stop codons at the tar-
geted site, no insertion of the donor sequence occurred. Identifi-
cation of the recombinant allele in the resulting pups was done by
PCR on genomic DNA purified from tail biopsies using primers
flanking the targeted region (F:5′-CCCGGATCCACCACTCTC-3′;
R: 5′-GAGCCCTTGCTCTTCAGC-3′ which originates a band of
311 bp for the WT allele. Mice for which the PCR product
displayed a shift in size were further Sanger sequenced. From
two initial founders, founder 8 displayed a modification that
originates a scrambled (+1 frameshift) and truncated protein.
Once the mutant sequence was determined, new primers were
designed that only anneal with the sequences in the WT (R: 5′-
GGACCCGGGCTCATGGTG-3′) or in the mutant genome (mutant
R: 5′-AGACGGGGACCCGGGTCT-3′). The selected founder was
backcrossed to B6 for two generations and heterozygotes inter-
crossed to generate the Ppic−/− mouse line.
Thymus transplants
Thymus transplants were performed as previously [14, 21, 22].
Briefly, thymi were harvested from WT newborn F1(B6xB6.SJL)
donor mice (CD45.1+CD45.2+), Ppic+/+ or Ppic−/− (CD45.2+).
Hosts were anesthetized with ketamine (100 mg/kg) and xylazine
(16 mg/kg), the kidney exposed, and the thymus lobes trans-
planted separately under the kidney capsule, one on each end
of the kidney. The kidney was then put back into the peri-
toneal cavity and the incision sutured and stapled closed. Hosts
received saline subcutaneously in the scruff and allowed to
recover in a heated pad. Mice were monitored in the follow-
ing day and transplants analyzed at the determined time points
post-transplant.
Flow cytometry
Single-cell suspensions from BM, thymus, and spleen were
prepared in PBS/10% FBS (PBS/FBS). Single-cell suspensions
from BM were prepared by flushing one tibia and femur per
mouse. Cell densities were determined using a hemocytometer
with trypan blue staining used to exclude dead cells. For staining,
all samples were first stained with Zombie-aqua (Biolegend
#423102) or LIVE/DEAD Fixable Near-IR (Invitrogen) according
to the manufacturer’s instructions. Blocking was done with mouse
IgG (Jackson ImmunoResearch Europe #015-000-003) followed
by staining with the appropriate combination of the following
antibodies purchased from BioLegend, unless otherwise stated:
Ter119-biotin (TER-119, #116204); CD11b-biotin (M1/70,
101204); CD11c-biotin (N418, #117304); CD19-biotin (6D5,
#115504); CD4-biotin (GK1.5, #100404); CD8-biotin (53-6.7,
#100704); CD3-biotin (145-2C11, #100304); Gr-1-biotin (RB6-
8C5, #108404); NK1.1-biotin (PK136, #108704); CD117-APC
(2B8, #105812); Sca1-PerCP/Cy5.5 (D7, #108124); CD127-
PE/Cy7 (A7R34, #135014); CD4-PE/Cy7 (GK1.5, #100422);
CD8-FITC (YTS169.8, in-house); CD25-BV605 (PC61, #102036);
NK1.1-PE (PK136, #108708); CD19-PE/Cy7 (6D5, #115520);
CD3-APC/Cy7 (145-2C11, #100330); CD4-BV605 (GK1.5,
#100451); CD8-PerCP/Cy5.5 (53-6.7, #100734); CD45.1-FITC
(A20, #110706); CD45.2-PB (104, #109820); CD8-BV711
(53-6.7, #100748); CD3-PE/Dazzle594 (17A2, #100245);
CD27-PB (LG.3A10, #124217); CD25-PE/Cy7 (PC61, #102016);
TCRγ1.1-FITC (2_11, #141104); TCRγ2-PE (UC3-10A6,
#137706); TCRγδ-bio (GL3, #118103); CD44-PerCP/Cy5.5
(IM7, #103032); CD117 APC/Cy7 (2B8, #105826); CD8-
BV711 (53-6.7, #100748); NK1.1-BV605 (PK136, #108740);
CD4-APC (RM4-5, BD Pharmingen #553051); CD25-PE (PC61,
#102008); CD8-APC (53-6.7, #100712); CD4-FITC (GK1.5, in
house); Foxp3-eFluor 450 (FJK-16S, eBioscience, # 48-5773-82);
CD19-BV711 (6D5, #115555); IgD-PerCP/Cy5.5 (11-26c.2a,
#405710); CD43-PE/Cy7 (S11, #143210); IgM-BV421 (RMM-1,
#406518); CD21/35-FITC (7G6, BD Pharmingen, #553818);
CD23-PE (B3B4, eBioscience, #12-0232-83); CD93-APC (AA4.1,
eBioscience, #17-5892-83); Gr-1-APC (RB6-8C5, #108412);
CD317-FITC (927, #127008); B220-PerCP/Cy5.5 (RA36B2,
#103236); F4/80-BV421 (BM8, #123131); CD11c-BV711
(N418, #117349); CD11b-BV785 (M1/70, #101243); MHC-
II-BV605 (M5/114.15.2, #107639); CD24-BV510 (M1/69,
#101831); CD44-BV605 (IM7, #103047); TCRβ-FITC (H57-
597, eBioscience, #11-5961-82); CD19-PerCP/Cy5.5 (ebio1D3,
eBioscience, #45-0193-82); NK1.1-PE/Cy7 (PK136, eBioscience,
#25-5941-82); CD4-APC (GK1.5, eBioscience, #17-0041-82);
CD1d tetramer loaded with PBS57 and coupled to BV421 (NIH
tetramer Core Facility); CD16/32-PE (93, #101307); CD135-APC
(A2F10, #135310); CD150-BV605 (TC15-12F12.2, #115927);
CD48-BV785 (HM48-1, #103449); CD34-BV421 (SA376A4,
#152208); CD19-PerCP/Cy5.5 (6D5, #115534); B220-PE
(RA36B2, BD, #553090); CD93-FITC (AA4.1, #136508);
CD24-APC (30F1, #138506). For stainings with biotinylated anti-
bodies, a secondary step of incubation with streptavidin-BV785
(#405249), streptavidin-APC/Cy7 (#405208), or streptavidin-
BV711 (#405241) was done. Each antibody staining step was
performed in PBS/FBS for 30 min on ice. For Foxp3 intracel-
lular detection, the True-NuclearTM Transcription factor buffer
set (Biolegend, #424401) was used according to the supplier’s
instructions. Briefly, cells were surface stained and then incubated
in 1× fix buffer for 45-60 min. After washing the cells in 1× perm
buffer, the Foxp3 antibody was added diluted in 1× perm buffer
and incubated at room temperature for 30 min. A final wash
in 1× perm buffer was performed and the cells resuspended in
PBS for FACS acquisition. FACS acquisition was performed on
an LSRFortessa X-20 (Becton Dickinson) controlled through BD
FACSDiva software (BD biosciences). FACS data were analyzed
using FlowJo (FlowJo, LLC). Cell number and other calculations
were performed in Excel (Microsoft) and plotted using Prism
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(Graphpad software). For identifying each cellular subset, all pop-
ulations were first gated in a lymphocyte gate in FSC versus SSC,
followed by doublet exclusion and dead cells were excluded using
a viability die. Specific populations were identified as follows:
Lineage−: Ter119−CD11b−CD11c−CD19−CD4−CD8−CD3−Gr-1−
NK1.1−; LSK: Sca-1+c-Kit+Lin−; LK: Sca-1−c-Kit+Lin−; HSC:
CD150+CD48−Sca-1+c-Kit+Lin−; LT-HSC: CD34−CD150+CD48−
Sca-1+c-Kit+Lin−; ST-HSC: CD34+CD150+CD48−Sca-1+c-Kit+
Lin−; MPP2: CD150+CD48+Sca-1+c-Kit+Lin−; MPP3: CD135lo/−
CD150−CD48+ Sca-1+c-Kit+Lin−; MPP4: CD135hiCD150−CD48+
Sca-1+c-Kit+Lin−; myeloid progenitors: CD127−Sca-1−c-Kit+
Lin−; CMP: CD34+CD16/32− CD127−Sca-1−c-Kit+Lin−; GMP:
CD34+CD16/32+CD127−Sca-1−c-Kit+Lin−; MEP: CD34−CD16/
32−CD127−Sca-1−c-Kit+Lin−; CLP: CD127+CD135+Lin−; Pre-
proB: B220+CD43+CD19−CD24−; proB: B220+CD43+
CD19+CD24+; early preB: B220+CD43+CD19+CD24hi; late preB:
B220loCD43−IgM−; immature B: B220hiCD43−IgM+CD93+;
mature B: B220hiCD43−IgM+CD93−; transitional B T1: CD19+
CD93+CD23−IgM+IgD−/lo; transitional B T2: CD19+CD93+
CD23+IgM+IgD−/lo; transitional B T3: CD19+CD93+CD23+
IgM−/loIgD+; Follicular B cells: CD19+CD93−CD23+CD43−
IgM−/loIgD+; Marginal zone B cells: CD19+CD93−CD23−CD21/
35hiCD43−IgM+IgD−/lo; B1 B cells: CD19+CD93−CD23−CD21/
35−CD43+IgM+IgD−/lo; DP: CD4+CD8+; CD8SP: CD4−CD8+
CD3+; CD4SP: CD4+CD8−; ISP: CD4−CD8+CD3−; DN:
CD4−CD8−; TN: CD4−CD8−CD3−; ETP: c-Kit+CD25−CD44+
CD4−CD8−CD3−; DN2: CD25+CD44+CD4−CD8−CD3−; DN2a:
c-Kit+CD25+CD44+CD4−CD8−CD3−; DN2b: c-Kit−/loCD25+
CD44+CD4−CD8−CD3−; DN3: CD25+CD44−CD4−CD8−CD3−;
DN4: CD25−CD44−CD4−CD8−CD3−; total CD3: CD3+; CD4 T:
CD4+CD8−CD3+CD19−CD11b−NK1.1−; CD8 T: CD4−CD8+
CD3+CD19−CD11b−NK1.1−; γδT cells: γδTCR+CD3+CD4−CD8−;
CD25+CD27+ γδT: CD25+CD27+ γδTCR+CD3+CD4−CD8−;
CD25−CD27+ γδT: CD25−CD27+ γδTCR+CD3+CD4−CD8−; Vγ1
γδT: Vγ1+Vγ4− γδTCR+CD3+CD4−CD8−; Vγ4 γδT: Vγ1−
Vγ4+ γδTCR+CD3+CD4−CD8−; Vγ1−Vγ4− γδT: Vγ1−Vγ4−
γδTCR+CD3+CD4−CD8−; iNKT: TCRβ+CD1d-PBS57-tet+; S0/S1
iNKT, CD4−NK1.1−TCRβ+CD1d-PBS57-tet+; S2 iNKT, CD4+
NK1.1−TCRβ+CD1d-PBS57-tet+; S3 iNKT: CD4+NK1.1+TCRβ+
CD1d-PBS57-tet+; CD4+NK1.1+ iNKT: CD4+NK1.1+TCRβ+
CD1d-PBS57-tet+; CD4+NK11− iNKT: CD4+NK1.1+TCRβ+CD1d-
PBS57-tet+; CD4−NK11− iNKT: CD4−NK11−TCRβ+CD1d-
PBS57-tet+; Macrophages: CD11b+F4/80+CD19−; Neu-
trophils: CD11b+Gr-1+F4/80−CD19−; Conventional DC:
CD11c+MHC-IIhiCD317−CD19−; Plasmacytoid DC, CD11c+MHC-
II+CD317+B220intCD19−; NK cells: NK1.1+CD3−CD19−; B cells
(in BM chimeras): CD19+; CD11b: CD11b+NK1.1−CD19−; in
the experiments of thymus transplants, a CD45.1+CD45.2+ gate
to identify donor origin and CD45.1−CD45.2+ to identify host
origin; in the experiments of BM chimeras competitor origin
was determined by gating on CD45.1+CD45.2− and test origin
by gating on CD45.1−CD45.2+. The flow cytometry work here
presented is in accordance with the guidelines for the use of flow
cytometry and cell sorting in immunological studies [23].
Bone marrow chimeras
F1(B6xB6.SJL) mice aged 8- to 12-week old were 7Gy-irradiated
and used as recipients for BM cells in the next day. Donor cell
suspensions were prepared from femurs and tibias, followed
by lineage depletion using biotin-binder Dynabeads (Invitrogen
#11047) according to the manufacturer’s recommendations. Irra-
diated mice received 1 × 106 lineage-negative enriched BM cells
consisting of Ppic+/+ or Ppic−/− (CD45.2+) cells mixed at a ratio
of 1:1 with CD45.1+ cells in 100 μL sterile PBS i.v. Recipient mice
were analyzed 8 weeks later. Similar results were obtained in an
independent experiment using 6 × 106 unfractioned donor BM
cells.
Statistical analysis
Data were tested for statistical significance using Mann–Whitney
U test in Prism version 7.01 (Graphpad, software).
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